Dime Commercial Bancshares, Inc. /NY/ Stock Compensation Disclosure
17. STOCK-BASED COMPENSATION
In May 2021, the Company’s stockholders approved the Dime Community Bancshares, Inc. 2021 Equity Incentive Plan (the “2021 Equity Incentive Plan”) to provide the Company with sufficient equity compensation to meet the objectives of appropriately incentivizing its officers, other employees, and directors to execute our strategic plan to build shareholder value, while providing appropriate shareholder protections. The Company no longer makes grants under the Legacy Stock Plans. Awards outstanding under the Legacy Stock Plans will continue to remain outstanding and subject to the terms and conditions of the Legacy Stock Plans. An additional 1,185,000 shares of common stock were reserved to be issued under the 2021 Equity Incentive Plan following stockholder approval at the Annual Meeting of Shareholders on May 23, 2024. At December 31, 2025, there were 1,196,586 shares reserved for issuance under the 2021 Equity Incentive Plan.
Stock Option Activity
The following table presents a summary of activity related to stock options granted under the Legacy Stock Plans, and changes during the period then ended:
| | Weighted- | | |||||||
Weighted- | Average | |||||||||
Average | Remaining | Aggregate | ||||||||
Number of | Exercise | Contractual | Intrinsic | |||||||
(Dollars in thousands except share and per share amounts) | | Options | | Price | | Years | | Value | ||
Options outstanding at January 1, 2025 | 26,995 | $ | 35.39 | 4.2 | $ | — | ||||
Options exercised | — |
| — | |||||||
Options forfeited | — |
| — | |||||||
Options outstanding at December 31, 2025 |
| 26,995 | $ | 35.39 |
| 3.2 | $ | — | ||
Options vested and exercisable at December 31, 2025 |
| 26,995 | $ | 35.39 |
| 3.2 | $ | — | ||
Information related to stock options during each period is as follows:
Year Ended December 31, | |||||||||
(In thousands) | 2025 | | 2024 | | 2023 | ||||
Cash received for option exercise cost | $ | — | $ | — | $ | — | |||
Income tax (expense) benefit recognized on stock option exercises |
| — |
| — |
| — | |||
Intrinsic value of options exercised |
| — |
| — |
| — | |||
The range of exercise prices and weighted-average remaining contractual lives of both outstanding and vested options (by option exercise cost) as of December 31, 2025 were as follows:
Outstanding Options | Vested Options | |||||||
Weighted | Weighted | |||||||
Average | Average | |||||||
Number | Contractual | Number | Contractual | |||||
of | Years | of | Years | |||||
| Options | | Remaining | | Options | | Remaining | |
Exercise Prices: |
| |
| |
| |
| |
$34.87 |
| 10,061 |
| 4.1 |
| 10,061 |
| 4.1 |
$35.35 |
| 9,802 |
| 3.1 |
| 9,802 |
| 3.1 |
$36.19 |
| 7,132 |
| 2.1 |
| 7,132 |
| 2.1 |
Total |
| 26,995 |
| 3.2 |
| 26,995 |
| 3.2 |
Restricted Stock Awards
The Company has made RSA grants to outside Directors and certain officers under the Legacy Stock Plans and the 2021 Equity Incentive Plan. Typically, awards to outside Directors fully vest on the first anniversary of the grant date, while awards to officers vest over a pre-determined requisite period. All awards were made at the fair value of the Company’s common stock on the grant date. Compensation expense on all RSAs is based upon the fair value of the shares on the respective dates of the grant.
The following table presents a summary of activity related to the RSAs granted, and changes during the period then ended:
| Weighted- | ||||
Average | |||||
Number of | Grant-Date | ||||
| Shares | | Fair Value | ||
Unvested allocated shares outstanding at January 1, 2025 | 470,236 | $ | 22.79 | ||
Shares granted |
| 252,905 |
| 28.15 | |
Shares vested | (241,319) | 24.21 | |||
Shares forfeited |
| (24,454) |
| 25.06 | |
Unvested allocated shares outstanding at December 31, 2025 |
| 457,368 | $ | 24.88 | |
Information related to RSAs during each period is as follows:
Year Ended December 31, | |||||||||
(In thousands) | 2025 | | 2024 | | 2023 | ||||
Compensation expense recognized | $ | 5,486 | $ | 5,780 | $ | 4,003 | |||
Income tax expense recognized on vesting of RSAs |
| (371) |
| (317) |
| (188) | |||
As of December 31, 2025, there was $6.6 million of total unrecognized compensation cost related to unvested RSAs to be recognized over a weighted-average period of 1.9 years.
Performance-Based Share Awards
The Company maintains a Long Term Incentive Plan (“LTIP”) for certain officers, which meets the criteria for equity-based accounting. For each award, threshold (50% of target), target (100% of target) and stretch (150% of target) opportunities are eligible to be earned over a three-year performance period based on the Company’s relative performance on certain goals that were established at the onset of the performance period and cannot be altered subsequently. Shares of common stock are issued on the grant date and held as unvested stock awards until the end of the performance period. Shares are issued at the stretch opportunity in order to ensure that an adequate number of shares are allocated for shares expected to vest at the end of the performance period. Compensation expense on PSAs is based upon the fair value of the shares on the date of the grant for the expected aggregate share payout as of the period end.
During the year ended December 31, 2025 and 2024, 102,002 shares and 96,049 shares were granted, respectively.
The following table presents a summary of activity related to the PSAs granted, and changes during the period then ended:
| Weighted- | ||||
Average | |||||
Number of | Grant-Date | ||||
| Shares | | Fair Value | ||
Maximum aggregate share payout at January 1, 2025 | 258,864 | $ | 18.69 | ||
Shares granted |
| 102,002 |
| 28.19 | |
Shares forfeited | (31,664) | 16.49 | |||
Shares vested | (21,704) | 28.04 | |||
Maximum aggregate share payout at December 31, 2025 |
| 307,498 | $ | 21.41 | |
Minimum aggregate share payout |
| — | — | ||
Expected aggregate share payout |
| 300,577 | $ | 21.36 | |
Information related to PSAs during each period is as follows:
Year Ended December 31, | |||||||||
(In thousands) | 2025 | | 2024 | | 2023 | ||||
Compensation expense recognized | $ | 2,197 | $ | 910 | $ | 635 | |||
Income tax benefit (expense) recognized on vesting of PSAs |
| 17 |
| (52) |
| — | |||
As of December 31, 2025, there was $2.8 million of total unrecognized compensation cost related to unvested PSAs based on the expected aggregate share payout to be recognized over a weighted-average period of 1.6 years.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 20, 2026 | Showing above |
| 2024 | Feb 20, 2025 | |
| 2023 | Feb 22, 2024 | |
| 2022 | Feb 28, 2023 | |
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.